Cytek Biosciences, Inc. CTKB Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s total current liabilities?
- Cytek Biosciences, Inc. (CTKB) reported total current liabilities of $80.94M in Q1 2026.
- How has Cytek Biosciences, Inc.'s total current liabilities changed year-over-year?
- Cytek Biosciences, Inc.'s total current liabilities increased by 19.6% year-over-year, from $67.69M to $80.94M.
- What is the long-term trend for Cytek Biosciences, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s total current liabilities has grown at a 24.0% compound annual growth rate (CAGR), from $26.54M to $77.8M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.